Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minchul Kim

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 14